Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathew Cherian

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
American Journal of Respiratory and Critical Care Medicine|July 6, 2023
Assessment of Preserved Ratio Impaired Spirometry Using Pre- and Post-Bronchodilator Spirometry in a Randomly Sampled Symptomatic CohortKate M A Magner, Mathew Cherian, G A Whitmore, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2019
Retrospective Analysis of Treatment Patterns and Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast CancerJing Xi, Aabha Oza, Shana Thomas, et al.
Clinical Neuroradiology|November 10, 2019
Endovascular Treatment Decision Making in Octogenarians and Nonagenarians : Insights from UNMASK EVT an International Multidisciplinary StudyJohanna Maria Ospel, Nima Kashani N, Bijoy Menon, et al.
Cardio-Oncology (London, England)|December 9, 2020
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancerSagar Sardesai, Jasmine Sukumar, Mahmoud Kassem, et al.
JACC. Case Reports|May 9, 2025
Pembrolizumab-Induced Smoldering Myocarditis in Patients With Triple-Negative Breast CancerAdnan Shaaban, Alma Habib, Dionisia Quiroga, et al.
Cancer Medicine|June 19, 2024
Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancerJasmine S Sukumar, Sagar Sardesai, Andy Ni, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 4, 2026
Denosumab as Second-Line Treatment in Patients With Metastatic Breast Cancer: A Retrospective Descriptive Pilot Study From a Single InstitutionBriana To, Laura E Wright, Dureti Doto, et al.
Journal of Clinical Medicine|July 27, 2022
Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship StrategiesMichael Grimm, Lindsey Radcliff, Mariann Giles, et al.
JACC. Asia|May 1, 2026
Association of Serum Uric Acid With Cardiovascular-Kidney-Metabolic Risk in a Rural Indian PopulationSundaresan Mohanraj, Samrat Ashok Vasudevan, Avinash Kumar Raghupathy, et al.
Breast Cancer Research and Treatment|December 16, 2025
Trimodal therapy is associated with higher overall survival than chemotherapy only in patients with metastatic inflammatory breast cancerEric Schupp, Yevgeniya Gokun, Jacob Eckstein, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
American Journal of Respiratory and Critical Care Medicine|July 6, 2023
Assessment of Preserved Ratio Impaired Spirometry Using Pre- and Post-Bronchodilator Spirometry in a Randomly Sampled Symptomatic CohortKate M A Magner, Mathew Cherian, G A Whitmore, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2019
Retrospective Analysis of Treatment Patterns and Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast CancerJing Xi, Aabha Oza, Shana Thomas, et al.
Clinical Neuroradiology|November 10, 2019
Endovascular Treatment Decision Making in Octogenarians and Nonagenarians : Insights from UNMASK EVT an International Multidisciplinary StudyJohanna Maria Ospel, Nima Kashani N, Bijoy Menon, et al.
Cardio-Oncology (London, England)|December 9, 2020
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancerSagar Sardesai, Jasmine Sukumar, Mahmoud Kassem, et al.
JACC. Case Reports|May 9, 2025
Pembrolizumab-Induced Smoldering Myocarditis in Patients With Triple-Negative Breast CancerAdnan Shaaban, Alma Habib, Dionisia Quiroga, et al.
Cancer Medicine|June 19, 2024
Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancerJasmine S Sukumar, Sagar Sardesai, Andy Ni, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 4, 2026
Denosumab as Second-Line Treatment in Patients With Metastatic Breast Cancer: A Retrospective Descriptive Pilot Study From a Single InstitutionBriana To, Laura E Wright, Dureti Doto, et al.
Journal of Clinical Medicine|July 27, 2022
Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship StrategiesMichael Grimm, Lindsey Radcliff, Mariann Giles, et al.
JACC. Asia|May 1, 2026
Association of Serum Uric Acid With Cardiovascular-Kidney-Metabolic Risk in a Rural Indian PopulationSundaresan Mohanraj, Samrat Ashok Vasudevan, Avinash Kumar Raghupathy, et al.
Breast Cancer Research and Treatment|December 16, 2025
Trimodal therapy is associated with higher overall survival than chemotherapy only in patients with metastatic inflammatory breast cancerEric Schupp, Yevgeniya Gokun, Jacob Eckstein, et al.
Pageof 13